Atrophy, Geographic
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 2/3 Study of ALK-001 in Geographic Atrophy (NCT03845582) | Alkeus Pharmaceuticals, Inc. | 2019-05-07 |
| Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers (NCT02033668) | GlaxoSmithKline | 2014-01-22 |
| Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration (NCT01342926) | GlaxoSmithKline | 2011-06-01 |
Track Atrophy, Geographic automatically
Every clearance here is in the API, with alerts when new ones post.